Contact
searchSearch
HMP Global

Pharmacy Learning Network

Featured

News
Testosterone Cypionate Injection Recalled Due to Crystallization Concerns
04/23/2025
Juliet Gallagher
Eugia US LLC has voluntarily recalled 36,816 vials of Testosterone Cypionate Injection, USP, CIII, 200 mg/mL, distributed in 1 mL single-dose vials (NDC 55150-277-01).
Eugia US LLC has voluntarily recalled 36,816 vials of Testosterone Cypionate Injection, USP, CIII, 200 mg/mL, distributed in 1 mL single-dose vials (NDC 55150-277-01).
Eugia US LLC has voluntarily...
04/23/2025
Pharmacy Learning Network
News
Class II Recall Issued for Unisom Sleep Aid Due to Nitrosamine Impurities
04/23/2025
Juliet Gallagher
Chattem Inc. has voluntarily initiated a Class II recall of its Unisom SleepMinis (Diphenhydramine HCl) 25 mg mini-capsules, distributed in 60-count bottles nationwide.
Chattem Inc. has voluntarily initiated a Class II recall of its Unisom SleepMinis (Diphenhydramine HCl) 25 mg mini-capsules, distributed in 60-count bottles nationwide.
Chattem Inc. has voluntarily...
04/23/2025
Pharmacy Learning Network
News
FDA Issues Class I Recall for Levetiracetam Injection Due to Labeling Discrepancy
04/23/2025
Juliet Gallagher
Dr Reddy’s Laboratories Inc. has initiated a Class I recall of levetiracetam 0.75% in sodium chloride injection following the discovery of a labeling discrepancy that could pose serious health risks.
Dr Reddy’s Laboratories Inc. has initiated a Class I recall of levetiracetam 0.75% in sodium chloride injection following the discovery of a labeling discrepancy that could pose serious health risks.
Dr Reddy’s Laboratories Inc. has...
04/23/2025
Pharmacy Learning Network
Ann Latner Headshot
Commentary
Class Action Suit Filed Against Maryland Med Center After Pharmacist Installs Spyware
04/23/2025
Ann W. Latner, JD
In a shocking case, the University of Maryland Medical Center (UMMC) is facing a class action lawsuit alleging that one of its pharmacists installed malicious software on hundreds of coworkers’ laptops and workstations over the course of a...
In a shocking case, the University of Maryland Medical Center (UMMC) is facing a class action lawsuit alleging that one of its pharmacists installed malicious software on hundreds of coworkers’ laptops and workstations over the course of a...
In a shocking case, the...
04/23/2025
Pharmacy Learning Network
Quiz
Mechanism of Action in Alzheimer Disease Medication
04/22/2025
What is the primary mechanism of action of FDA-approved drug Lecanemab (Leqembi) in treating early Alzheimer’s disease?
What is the primary mechanism of action of FDA-approved drug Lecanemab (Leqembi) in treating early Alzheimer’s disease?
What is the primary mechanism of...
04/22/2025
Pharmacy Learning Network
News
FDA Issues Class II Recall for Sodium Chloride Irrigation Solution Due to Particulate Contamination
04/17/2025
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for Sodium Chloride Irrigation Solution due to the presence of particulate matter, posing a potential risk during surgical and wound care procedures.
The US Food and Drug Administration (FDA) has issued a Class II recall for Sodium Chloride Irrigation Solution due to the presence of particulate matter, posing a potential risk during surgical and wound care procedures.
The US Food and Drug...
04/17/2025
Pharmacy Learning Network
News
Gabapentin Capsules Recalled Due to Cross-Contamination Concerns
04/17/2025
Hannah Musick
Select lots of nationally distributed Gabapentin Capsules are being recalled due to cross contamination concerns.
Select lots of nationally distributed Gabapentin Capsules are being recalled due to cross contamination concerns.
Select lots of nationally...
04/17/2025
Pharmacy Learning Network
News
FDA Issues Class II Recalls for Multiple Injectable Products Due to Sterility Concerns
04/17/2025
Hannah Musick
The US Food and Drug Administration (FDA) has issued Class II recalls for multiple injectable products, including Haloperidol Decanoate and Methocarbamol, due to potential sterility issues linked to bacterial contamination during...
The US Food and Drug Administration (FDA) has issued Class II recalls for multiple injectable products, including Haloperidol Decanoate and Methocarbamol, due to potential sterility issues linked to bacterial contamination during...
The US Food and Drug...
04/17/2025
Pharmacy Learning Network
Ann Latner Headshot
Commentary
Pharmacy Residents Sue ASHP, Hospitals, Over Wage Fixing
04/16/2025
Ann W. Latner, JD
Two former pharmacy residents, on behalf of themselves and other pharmacy residents, have filed a class action lawsuit against the American Society of Health-System Pharmacists (ASHP), National Matching Services, and about a dozen...
Two former pharmacy residents, on behalf of themselves and other pharmacy residents, have filed a class action lawsuit against the American Society of Health-System Pharmacists (ASHP), National Matching Services, and about a dozen...
Two former pharmacy residents,...
04/16/2025
Pharmacy Learning Network
News
FDA Class III Recall: Tolterodine Tartrate ER Capsules by Major Pharmaceuticals
04/10/2025
Danielle Sposato
A nationwide recall has been initiated for Tolterodine Tartrate Extended-Release Capsules, 2 mg, packaged in 30-count unit dose cartons (NDC 0904-6592-04), and distributed by Major Pharmaceuticals of Indianapolis, IN.
A nationwide recall has been initiated for Tolterodine Tartrate Extended-Release Capsules, 2 mg, packaged in 30-count unit dose cartons (NDC 0904-6592-04), and distributed by Major Pharmaceuticals of Indianapolis, IN.
A nationwide recall has been...
04/10/2025
Pharmacy Learning Network
News
Imprimis NJOF Voluntarily Recalls Ophthalmic Solution Due to Subpotency
04/10/2025
Danielle Sposato
Imprimis NJOF, LLC has issued a voluntary recall of its Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution (1% / 0.5% / 2.5% / 0.5%) after stability testing revealed subpotent results.
Imprimis NJOF, LLC has issued a voluntary recall of its Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution (1% / 0.5% / 2.5% / 0.5%) after stability testing revealed subpotent results.
Imprimis NJOF, LLC has issued a...
04/10/2025
Pharmacy Learning Network

News

News
Testosterone Cypionate Injection Recalled Due to Crystallization Concerns
04/23/2025
Juliet Gallagher
Eugia US LLC has voluntarily recalled 36,816 vials of Testosterone Cypionate Injection, USP, CIII, 200 mg/mL, distributed in 1 mL single-dose vials (NDC 55150-277-01).
Eugia US LLC has voluntarily recalled 36,816 vials of Testosterone Cypionate Injection, USP, CIII, 200 mg/mL, distributed in 1 mL single-dose vials (NDC 55150-277-01).
Eugia US LLC has voluntarily...
04/23/2025
Pharmacy Learning Network
News
Class II Recall Issued for Unisom Sleep Aid Due to Nitrosamine Impurities
04/23/2025
Juliet Gallagher
Chattem Inc. has voluntarily initiated a Class II recall of its Unisom SleepMinis (Diphenhydramine HCl) 25 mg mini-capsules, distributed in 60-count bottles nationwide.
Chattem Inc. has voluntarily initiated a Class II recall of its Unisom SleepMinis (Diphenhydramine HCl) 25 mg mini-capsules, distributed in 60-count bottles nationwide.
Chattem Inc. has voluntarily...
04/23/2025
Pharmacy Learning Network
News
FDA Issues Class I Recall for Levetiracetam Injection Due to Labeling Discrepancy
04/23/2025
Juliet Gallagher
Dr Reddy’s Laboratories Inc. has initiated a Class I recall of levetiracetam 0.75% in sodium chloride injection following the discovery of a labeling discrepancy that could pose serious health risks.
Dr Reddy’s Laboratories Inc. has initiated a Class I recall of levetiracetam 0.75% in sodium chloride injection following the discovery of a labeling discrepancy that could pose serious health risks.
Dr Reddy’s Laboratories Inc. has...
04/23/2025
Pharmacy Learning Network
News
FDA Issues Class II Recall for Sodium Chloride Irrigation Solution Due to Particulate Contamination
04/17/2025
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for Sodium Chloride Irrigation Solution due to the presence of particulate matter, posing a potential risk during surgical and wound care procedures.
The US Food and Drug Administration (FDA) has issued a Class II recall for Sodium Chloride Irrigation Solution due to the presence of particulate matter, posing a potential risk during surgical and wound care procedures.
The US Food and Drug...
04/17/2025
Pharmacy Learning Network
News
Gabapentin Capsules Recalled Due to Cross-Contamination Concerns
04/17/2025
Hannah Musick
Select lots of nationally distributed Gabapentin Capsules are being recalled due to cross contamination concerns.
Select lots of nationally distributed Gabapentin Capsules are being recalled due to cross contamination concerns.
Select lots of nationally...
04/17/2025
Pharmacy Learning Network
News
FDA Issues Class II Recalls for Multiple Injectable Products Due to Sterility Concerns
04/17/2025
Hannah Musick
The US Food and Drug Administration (FDA) has issued Class II recalls for multiple injectable products, including Haloperidol Decanoate and Methocarbamol, due to potential sterility issues linked to bacterial contamination during...
The US Food and Drug Administration (FDA) has issued Class II recalls for multiple injectable products, including Haloperidol Decanoate and Methocarbamol, due to potential sterility issues linked to bacterial contamination during...
The US Food and Drug...
04/17/2025
Pharmacy Learning Network
News
FDA Class III Recall: Tolterodine Tartrate ER Capsules by Major Pharmaceuticals
04/10/2025
Danielle Sposato
A nationwide recall has been initiated for Tolterodine Tartrate Extended-Release Capsules, 2 mg, packaged in 30-count unit dose cartons (NDC 0904-6592-04), and distributed by Major Pharmaceuticals of Indianapolis, IN.
A nationwide recall has been initiated for Tolterodine Tartrate Extended-Release Capsules, 2 mg, packaged in 30-count unit dose cartons (NDC 0904-6592-04), and distributed by Major Pharmaceuticals of Indianapolis, IN.
A nationwide recall has been...
04/10/2025
Pharmacy Learning Network
News
Imprimis NJOF Voluntarily Recalls Ophthalmic Solution Due to Subpotency
04/10/2025
Danielle Sposato
Imprimis NJOF, LLC has issued a voluntary recall of its Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution (1% / 0.5% / 2.5% / 0.5%) after stability testing revealed subpotent results.
Imprimis NJOF, LLC has issued a voluntary recall of its Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution (1% / 0.5% / 2.5% / 0.5%) after stability testing revealed subpotent results.
Imprimis NJOF, LLC has issued a...
04/10/2025
Pharmacy Learning Network
News
Class II Recall Issued for Chlorpromazine Tablets Due to Nitrosamine Impurity
04/10/2025
Danielle Sposato
Glenmark Pharmaceuticals Inc., USA has initiated a voluntary Class II recall of its chlorproMAZINE Hydrochloride Tablets, USP 100 mg, due to current Good Manufacturing Practice (CGMP) deviations
Glenmark Pharmaceuticals Inc., USA has initiated a voluntary Class II recall of its chlorproMAZINE Hydrochloride Tablets, USP 100 mg, due to current Good Manufacturing Practice (CGMP) deviations
Glenmark Pharmaceuticals Inc.,...
04/10/2025
Pharmacy Learning Network
News
FDA Issues Class II Recall for QuVa Pharma Compounded Epidural Drug Products Due to Sterility Concerns
04/03/2025
Juliet Gallagher
QuVa Pharma, Inc. has voluntarily initiated a nationwide Class II recall of multiple compounded epidural drug formulations containing fentanyl citrate combined with bupivacaine or ropivacaine.
QuVa Pharma, Inc. has voluntarily initiated a nationwide Class II recall of multiple compounded epidural drug formulations containing fentanyl citrate combined with bupivacaine or ropivacaine.
QuVa Pharma, Inc. has...
04/03/2025
Pharmacy Learning Network

Commentary

Ann Latner Headshot
Commentary
Class Action Suit Filed Against Maryland Med Center After Pharmacist Installs Spyware
04/23/2025
Ann W. Latner, JD
In a shocking case, the University of Maryland Medical Center (UMMC) is facing a class action lawsuit alleging that one of its pharmacists installed malicious software on hundreds of coworkers’ laptops and workstations over the course of a...
In a shocking case, the University of Maryland Medical Center (UMMC) is facing a class action lawsuit alleging that one of its pharmacists installed malicious software on hundreds of coworkers’ laptops and workstations over the course of a...
In a shocking case, the...
04/23/2025
Pharmacy Learning Network
Ann Latner Headshot
Commentary
Pharmacy Residents Sue ASHP, Hospitals, Over Wage Fixing
04/16/2025
Ann W. Latner, JD
Two former pharmacy residents, on behalf of themselves and other pharmacy residents, have filed a class action lawsuit against the American Society of Health-System Pharmacists (ASHP), National Matching Services, and about a dozen...
Two former pharmacy residents, on behalf of themselves and other pharmacy residents, have filed a class action lawsuit against the American Society of Health-System Pharmacists (ASHP), National Matching Services, and about a dozen...
Two former pharmacy residents,...
04/16/2025
Pharmacy Learning Network
Ann Latner Headshot
Commentary
Settlement Reached in Hi-School Pharmacy Data Breach
04/08/2025
Ann W. Latner, JD
A $600 000 proposed settlement has been reached in a cybersecurity/data breach class action case against Hi-School Pharmacy.
A $600 000 proposed settlement has been reached in a cybersecurity/data breach class action case against Hi-School Pharmacy.
A $600 000 proposed settlement...
04/08/2025
Pharmacy Learning Network
Ann Latner Headshot
Commentary
FTC Releases Second Interim Report on Prescription Drug Middlemen
03/27/2025
Ann W. Latner, JD
The Federal Trade Commission (FTC) published its second interim staff report on the prescription drug middlemen industry in early 2025. The report focuses on pharmacy benefits managers’ (PBMs’) influence over specialty generic drugs.
The Federal Trade Commission (FTC) published its second interim staff report on the prescription drug middlemen industry in early 2025. The report focuses on pharmacy benefits managers’ (PBMs’) influence over specialty generic drugs.
The Federal Trade Commission...
03/27/2025
Pharmacy Learning Network
Ann Latner Headshot
Commentary
New York Pharmacist Arrested for Illegal Dispensing
03/20/2025
Ann W. Latner, JD
The New York State Police have announced the arrest of pharmacist Clyde Stevens, 46, of Binghamton, NY following an investigation at a Rite Aid pharmacy in Endwell, NY.
The New York State Police have announced the arrest of pharmacist Clyde Stevens, 46, of Binghamton, NY following an investigation at a Rite Aid pharmacy in Endwell, NY.
The New York State Police have...
03/20/2025
Pharmacy Learning Network
Ann Latner Headshot
Commentary
Kroger Agrees to Pay $110 Million to Resolve Kentucky Opioid Lawsuit
03/13/2025
Ann W. Latner, JD
Kentucky Attorney General Russell Coleman has announced a multimillion-dollar settlement in the state’s case against Kroger. The Case The state of Kentucky alleged that Kroger helped fuel a deadly opioid epidemic by flooding communities...
Kentucky Attorney General Russell Coleman has announced a multimillion-dollar settlement in the state’s case against Kroger. The Case The state of Kentucky alleged that Kroger helped fuel a deadly opioid epidemic by flooding communities...
Kentucky Attorney General...
03/13/2025
Pharmacy Learning Network
Ann Latner Headshot
Commentary
Pharmacists Sent to Prison for Insurance Fraud
03/07/2025
Ann W. Latner, JD
The US Department of Justice has announced that 4 pharmacy owners have been sentenced to prison following their convictions by a federal jury for health care and wire fraud.
The US Department of Justice has announced that 4 pharmacy owners have been sentenced to prison following their convictions by a federal jury for health care and wire fraud.
The US Department of Justice has...
03/07/2025
Pharmacy Learning Network
Ann Latner Headshot
Commentary
Former Pharmacy Student Settles Lawsuit Against School Over Social Media Posts
02/25/2025
Ann W. Latner, JD
A fascinating case that began in 2021 has finally settled, with pharmacist Kimberly Diei receiving $250 000 from her former pharmacy school.
A fascinating case that began in 2021 has finally settled, with pharmacist Kimberly Diei receiving $250 000 from her former pharmacy school.
A fascinating case that began in...
02/25/2025
Pharmacy Learning Network
Ann Latner Headshot
Commentary
CVS Responds to Justice Department Lawsuit
02/20/2025
Ann W. Latner, JD
As we wrote about last month, at the end of 2024 the US Department of Justice filed a nationwide lawsuit against pharmacy giant CVS, alleging that the chain was unlawfully dispensing massive quantities of opioids and other controlled...
As we wrote about last month, at the end of 2024 the US Department of Justice filed a nationwide lawsuit against pharmacy giant CVS, alleging that the chain was unlawfully dispensing massive quantities of opioids and other controlled...
As we wrote about last month, at...
02/20/2025
Pharmacy Learning Network
Ann Latner Headshot
Commentary
Insulin Pricing Lawsuit Filed by Massachusetts Attorney General
02/10/2025
Ann W. Latner, JD
Joy Campbell, Massachusetts attorney general, has filed a lawsuit against a slew of defendants, including insulin manufacturers Eli Lilly, Sanofi, Novo Nordisk, as well as pharmacy benefit managers (PBMs) Optum Rx, Express Scripts, and CVS...
Joy Campbell, Massachusetts attorney general, has filed a lawsuit against a slew of defendants, including insulin manufacturers Eli Lilly, Sanofi, Novo Nordisk, as well as pharmacy benefit managers (PBMs) Optum Rx, Express Scripts, and CVS...
Joy Campbell, Massachusetts...
02/10/2025
Pharmacy Learning Network

Interviews

Vishali Amin
Interview
The State of Drug Affordability Programs and Reformation Solutions
01/29/2024
Vishali Amin, PharmD
In this interview, Vishali Amin, VP of Value Delivery at Kalderos, discusses the impact of drug affordability on Medicare patients and medical costs, as well as the barriers preventing patients from benefiting from existing programs, the need...
In this interview, Vishali Amin, VP of Value Delivery at Kalderos, discusses the impact of drug affordability on Medicare patients and medical costs, as well as the barriers preventing patients from benefiting from existing programs, the need...
In this interview, Vishali Amin,...
01/29/2024
Pharmacy Learning Network
Guy Headshot
Interview
Securing the Medical Supply Chain: Addressing RSV Drug Shortages With IoT-Enabled Condition Monitoring in the Health Care Industry
12/12/2023
Guy Yehiav
With the increase in supply chain shortages, Guy Yehiav offers expert insights into conditioning monitoring's impact on antibody drug dosages for RSV. 
With the increase in supply chain shortages, Guy Yehiav offers expert insights into conditioning monitoring's impact on antibody drug dosages for RSV. 
With the increase in supply...
12/12/2023
Pharmacy Learning Network
Interview
Systemic and Topical Treatments For Atopic Dermatitis
10/31/2023
Derek Chu, MD, PhD, FRCPC
In this feature interview, Dr Derek Chu discusses systemic treatments for atopic dermatitis and also how physicians can consider the benefits and harms of prescription topical treatments.
In this feature interview, Dr Derek Chu discusses systemic treatments for atopic dermatitis and also how physicians can consider the benefits and harms of prescription topical treatments.
In this feature interview, Dr...
10/31/2023
Pharmacy Learning Network
Interview
Viewpoints on Integrative Dermatology, Part 2
10/26/2023
Sarah L. Taylor, MD, MPH, BS 
In this second installment of a series exploring integrative approaches in dermatology, Dr Sarah Taylor shares her insights from 20 years of working with alternative treatments.
In this second installment of a series exploring integrative approaches in dermatology, Dr Sarah Taylor shares her insights from 20 years of working with alternative treatments.
In this second installment of a...
10/26/2023
Pharmacy Learning Network
Interview
Viewpoints on Integrative Dermatology, Part 1
10/25/2023
Peter Lio, MD, FAAD
Do you have patients asking about alternative treatment options? In this first installment of a series exploring integrative approaches in dermatology, Dr Peter Lio answers key questions to help you navigate the journey.
Do you have patients asking about alternative treatment options? In this first installment of a series exploring integrative approaches in dermatology, Dr Peter Lio answers key questions to help you navigate the journey.
Do you have patients asking...
10/25/2023
Pharmacy Learning Network
Interview
Once-Daily, Single-Tablet Combination Therapy of Macitentan, Tadalafil in the Management of Patients With PAH
10/21/2023
James F. List, MD, PhD
In this interview, James F. List, MD, PhD, Global Therapeutic Area Head, whose team oversees a portfolio of programs including Pulmonary Hypertension at Janssen Research & Development, LLC, explains the A DUE study.
In this interview, James F. List, MD, PhD, Global Therapeutic Area Head, whose team oversees a portfolio of programs including Pulmonary Hypertension at Janssen Research & Development, LLC, explains the A DUE study.
In this interview, James...
10/21/2023
Pharmacy Learning Network
Headshot of Anita Patel, PharmD, Walgreens
Interview
Impact of COVID-19 Vaccines on Patients, Health Systems
12/21/2022
Maria Asimopoulos
Anita Patel, PharmD, vice president of pharmacy service development, Walgreens, reviews the effectiveness of COVID-19 vaccines as well as the role of pharmacies in ensuring patients are vaccinated throughout the winter.
Anita Patel, PharmD, vice president of pharmacy service development, Walgreens, reviews the effectiveness of COVID-19 vaccines as well as the role of pharmacies in ensuring patients are vaccinated throughout the winter.
Anita Patel, PharmD, vice...
12/21/2022
Integrated Healthcare Executive
Headshot of Reetu Mukherji, MD, Georgetown University
Interview
Evaluating a Digital Tool for Monitoring Drug Toxicities in Patients With Colorectal Cancer
12/12/2022
Maria Asimopoulos
Reetu Mukherji, MD, gastrointestinal medical oncologist, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, discusses findings from her recent study which tested the feasibility of using a smartphone app to monitor...
Reetu Mukherji, MD, gastrointestinal medical oncologist, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, discusses findings from her recent study which tested the feasibility of using a smartphone app to monitor...
Reetu Mukherji, MD,...
12/12/2022
Pharmacy Learning Network
Headshot of Nicole L Stout, DPT, CLT-LANA, FAPTA
Interview
Enhancing Distress Screening, Management Across Cancer Care Delivery Settings
11/23/2022
Samantha Matthews
Nicole L Stout, DPT, CLT-LANA, FAPTA, research assistant professor in the School of Medicine, Department of Hematology/Oncology, West Virginia University Cancer Institute, shares her team’s research on distress screening and a quality...
Nicole L Stout, DPT, CLT-LANA, FAPTA, research assistant professor in the School of Medicine, Department of Hematology/Oncology, West Virginia University Cancer Institute, shares her team’s research on distress screening and a quality...
Nicole L Stout, DPT, CLT-LANA,...
11/23/2022
Pharmacy Learning Network
Headshot of Safiya Karim
Interview
Discussing Association of Medical Cannabis, Prescription Opioid Use Among Patients With Cancer
10/18/2022
Edan Stanley
Safiya Karim, MD MSc FRCPC, clinical associate professor, medical oncologist, Tom Baker Cancer Centre, University of Calgary, offers insight from her team’s research on the relationship between medical cannabis and continuation of...
Safiya Karim, MD MSc FRCPC, clinical associate professor, medical oncologist, Tom Baker Cancer Centre, University of Calgary, offers insight from her team’s research on the relationship between medical cannabis and continuation of...
Safiya Karim, MD MSc FRCPC,...
10/18/2022
Pharmacy Learning Network

Podcasts

PopHealth Perspectives Stephen Crystal Part 2
PopHealth Perspectives
Addressing Prescription Drug Pricing: Fixing an Unsustainable Situation
12/28/2023
Stephen Crystal, PhD
Join us for part two of a conversation about soaring US prescription drug prices, the need for Medicare price negotiation, and proposed structural changes with Stephen Crystal, PhD, Director of the Rutgers Center for Health Services Research...
Join us for part two of a conversation about soaring US prescription drug prices, the need for Medicare price negotiation, and proposed structural changes with Stephen Crystal, PhD, Director of the Rutgers Center for Health Services Research...
Join us for part two of a...
12/28/2023
Pharmacy Learning Network
Crystal
Podcasts
Addressing Prescription Drug Pricing: The Urgent Need for Price Negotiation in Medicare
12/13/2023
Stephen Crystal, PhD
Join us for a conversation about soaring US prescription drug prices, the need for Medicare price negotiation, and proposed structural changes with Stephen Crystal, PhD, Director of the Rutgers Center for Health Services Research and...
Join us for a conversation about soaring US prescription drug prices, the need for Medicare price negotiation, and proposed structural changes with Stephen Crystal, PhD, Director of the Rutgers Center for Health Services Research and...
Join us for a conversation about...
12/13/2023
Pharmacy Learning Network
Headshot of Stephanie Ostling Mason, Glytec, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Improving Glycemic Management for Better Outcomes, Cost Savings
12/07/2022
Maria Asimopoulos
Stephanie Ostling Mason, PharmD, CDCES, diabetes clinical pharmacist, Glytec, shares the challenges associated with insulin management in the hospital setting and offers advice to improve patient outcomes.
Stephanie Ostling Mason, PharmD, CDCES, diabetes clinical pharmacist, Glytec, shares the challenges associated with insulin management in the hospital setting and offers advice to improve patient outcomes.
Stephanie Ostling Mason, PharmD,...
12/07/2022
Pharmacy Learning Network
Headshot of Eric Tichy on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Drug Spending Trends: Biosimilars, COVID-19 Therapies, and More
09/28/2022
Maria Asimopoulos
Eric Tichy, PharmD, MBA, vice chair of pharmacy formulary, Mayo Clinic, offers insight into drug spending trends that emerged over the course of 2021 and predicts how spending will continue to change as the pandemic wanes and inflation...
Eric Tichy, PharmD, MBA, vice chair of pharmacy formulary, Mayo Clinic, offers insight into drug spending trends that emerged over the course of 2021 and predicts how spending will continue to change as the pandemic wanes and inflation...
Eric Tichy, PharmD, MBA, vice...
09/28/2022
Integrated Healthcare Executive
Headshot of Michael Ganio, ASHP, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Monkeypox Vaccines: Current Options, Considerations for Patient Education
09/28/2022
Maria Asimopoulos
Michael Ganio, PharmD, MS, senior director of pharmacy practice and quality, American Society of Health-System Pharmacists, discusses measures being taken to address the rise in monkeypox cases in the United States and reviews the efficacy of...
Michael Ganio, PharmD, MS, senior director of pharmacy practice and quality, American Society of Health-System Pharmacists, discusses measures being taken to address the rise in monkeypox cases in the United States and reviews the efficacy of...
Michael Ganio, PharmD, MS,...
09/28/2022
Pharmacy Learning Network

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
David T. Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Paul Schulz, MD
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
Ronald Vender, MD, FRCPC
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
Abigail Cline, MD, PhD
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; Ryan Nix, BS, NRP, NCI
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Correlation Between Opioid Overdoses With Alcohol, Benzodiazepine Use
Videos
Correlation Between Opioid Overdoses With Alcohol, Benzodiazepine Use
05/13/2020
Marco Tori, MD, Department of Medicine, Boston University School of Medicine, discusses why alcohol and benzodiazepine co-involvement was common among opioid overdose-related deaths.
Marco Tori, MD, Department of Medicine, Boston University School of Medicine, discusses why alcohol and benzodiazepine co-involvement was common among opioid overdose-related deaths.
Marco Tori, MD, Department of...
05/13/2020
Pharmacy Learning Network
Videos
Diabetes - Guideline Changes, Adherence, and Newer Drug Issues
09/15/2015
09/15/2015
Pharmacy Learning Network

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use